Tepotinib in METex14 skipping alteration NSCLC

Enriqueta Felip, MD, PhD, of Vall dHebron University Hospital, Barcelona, Spain, discusses the VISION trial (NCT02864992) of tepotinib for non-small cell lung cancer (NSCLC) patients with MET exon 14... Author: VJOncology Added: 08/03/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts